Form 4 Filing for Apyx Medical Corp - Officer/Director Transaction

Lawrence Waldman, a director at Apyx Medical Corp, was granted a stock option on June 11, 2026. The option is for 50,000 shares of Common Stock with an exercise price of $4.65 per share and an expiration date of June 11, 2036. This option will vest ratably over twelve months, with full vesting occurring on the first anniversary of the grant date. Following this transaction, Waldman directly owns 50,000 shares.